In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vedanta Biosciences Inc.

www.vedantabio.com

Latest From Vedanta Biosciences Inc.

Sanger Institute Spin-Out Microbiotica To Evaluate Bacterial Mixes

The UK Wellcome Trust Sanger Institute’s latest spin-out has received start-up funding to exploit more than six years of gut bacterial genome sequencing in order to develop novel bacteria-based therapies for a range of diseases.

StartUps and SMEs Financing

Tech Transfer Roundup: Voyager Brings Home Pair Of CNS Collaborations

Collaboration with Washington University to co-develop therapies targeting apoliprotein A makes up part of Denali's big August push in Alzheimer's. Kleo gets global rights to two Yale antibody programs and raises Series A cash.

Deals Commercial

Venture Funding Deals, July 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced May through June.

BioPharmaceutical Medical Device

Vedanta Raises $50 Million For Microbiome Candidate Trials

Vedanta Biosciences, which is developing a new class of therapies designed to modulate the human microbiome, has raised $50 million through new equity investments to advance several of its programs into the clinic.

BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Gastrointestinal
  • Immune Disorders
  • Inflammation
  • Alias(es)
  • Vedanta Biosciences
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Vedanta Biosciences Inc.
  • Senior Management
  • Bernat Olle, PhD, CEO
    Bruce L Roberts, PhD, CSO
  • Contact Info
  • Vedanta Biosciences Inc.
    Phone: (857) 706-1427
    19 Blackstone St. 3rd Fl.
    Cambridge, MA 02116
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register